CDC report says 2025–2026 RSV season ran late with lower hospitalization rates
SARS-CoV-2 peaked in August 2025 and January 2026, and new national surveillance provisionally counted 34 RSV-associated and 31 COVID-19–associated pediatric deaths.
Key takeaways
- A CDC report dated November 19, 2026 says RSV activity occurred unusually late in most U.S. regions during July 2025–June 2026.
- Annual RSV-associated hospitalization rates were 790.2 per 100,000 for infants younger than 12 months and 352.1 per 100,000 for adults 75 and older.
- COVID-19–associated hospitalization rates were highest among adults 75 and older, at 361.2, followed by infants younger than 6 months, at 173.3.
- New national pediatric mortality surveillance provisionally identified 34 RSV-associated deaths from 35 jurisdictions and 31 COVID-19–associated deaths from 43 jurisdictions.
- SARS-CoV-2 peaked in August 2025 and January 2026; most sequenced viruses were JN.1 descendants, while BA.3.2 detections increased.
Respiratory syncytial virus (RSV) activity arrived unusually late in most U.S. regions during the past respiratory season, and RSV-associated hospitalization rates did not exceed those of the prior three seasons, according to a CDC report dated November 19, 2026. The report, "Respiratory Virus Activity - United States, July 2025–June 2026," lists Amber K. Winn, DrPH, as first author. [1]
SARS-CoV-2 circulated nationally with peaks in August 2025 and January 2026, the authors wrote. Most sequenced SARS-CoV-2 viruses were descendants of the JN.1 lineage, but detections of BA.3.2, which the report calls "a highly divergent SARS-CoV-2 variant," increased. [1]
The report also gives the first results from a newly established national system for tracking pediatric deaths. It provisionally identified 34 pediatric deaths associated with RSV, reported from 35 jurisdictions, and 31 associated with COVID-19, from 43 jurisdictions. [1]
What the records show
The analysis draws on six public health surveillance systems and covers weeks ending July 5, 2025 through June 27, 2026. Data were current as of July 22, 2026 unless the report specifies otherwise. The systems include laboratory test reporting (NREVSS), hospitalization networks for RSV and COVID-19 (RSV-NET and COVID-NET), the New Vaccine Surveillance Network, pediatric mortality reporting, and genomic sequencing. [1]
Annual RSV-associated hospitalization rates, expressed per 100,000 persons, were highest in the youngest children and the oldest adults. [1]
| Age group | RSV-associated hospitalization rate | 95% CI |
|---|---|---|
| Infants younger than 12 months | 790.2 | 757.9–825.3 |
| Children 12–23 months | 611.9 | 586.3–639.8 |
| Adults 75 years and older | 352.1 | 309.9–407.7 |
The report states that annual RSV rates, overall and by age group, stayed at or below the levels seen during 2022–2025. [1]
For COVID-19, the highest hospitalization rates were among adults 75 and older (361.2), infants younger than 6 months (173.3), and adults aged 65–74 years (111.4). The abstract does not give confidence intervals for those figures. [1]
On virus genetics, sequencing of RSV found no substitutions linked to reduced susceptibility to the monoclonal antibodies available for infants. For SARS-CoV-2, the report's summary says "this is the second consecutive year during which a major SARS-CoV-2 strain replacement did not occur." [1]
The authors defined RSV season onset and offset by the first and last of 2 consecutive weeks in which at least 3% of weekly RSV tests were positive. Other respiratory viruses tracked by CDC, including human metapneumovirus, rhinoviruses and enteroviruses, parainfluenza viruses, common human coronaviruses and respiratory adenoviruses, followed their usual historical patterns, according to the report. [1]
Why it matters for clinicians
The report places the heaviest hospitalization burden at the two ends of the age range. Infants in their first year had the highest RSV rate, and adults 75 and older had the highest COVID-19 rate and the third-highest RSV rate. Infants younger than 6 months ranked second for COVID-19 hospitalization, ahead of adults aged 65–74 years. [1]
Timing is the other finding with operational weight. The authors wrote that respiratory virus seasonality varies from year to year, which affects when vaccination is timed and how health care systems prepare. A late RSV season and a SARS-CoV-2 pattern with a summer and a winter peak mean the two viruses did not follow a single shared calendar in 2025–2026. [1]
The report's stated position on prevention is that staying current with recommended RSV and COVID-19 vaccinations "reduces the risk for severe illness" from these viruses. The portion of the report available does not address EMS call volume, transport patterns or emergency department visits. [1]
What the records do not tell us
- The pediatric death counts are provisional, reported as of August 11, 2026, and cover deaths during September 28, 2025–June 30, 2026. Not every jurisdiction reported. The authors wrote that "some deaths are likely missed because counts are provisional." [1]
- Thirty-one jurisdictions conducted their surveillance for the period retrospectively, the report says. [1]
- The available text does not name the jurisdictions that reported, and it does not give ages or other details of the children who died. [1]
- The available text does not state how many weeks later RSV activity began compared with earlier seasons, or the specific onset and peak dates by region. [1]
- The report mentions interim national modeling estimates for RSV and COVID-19, but the text available for this article cuts off before those figures. [1]
- Influenza is not covered. CDC says it summarizes influenza activity separately. [1]
- The available text does not report how much BA.3.2 detections increased or what share of sequenced viruses the variant represented. [1]
What to watch
The pediatric mortality figures are labeled provisional, so the counts may change as reporting is completed. The report does not give a date for final numbers. The authors wrote that prevention, treatment and preparedness strategies "require continued monitoring." [1]
Questions readers ask
Was the 2025–2026 RSV season late in the United States?
Yes. A CDC report dated November 19, 2026 says RSV activity occurred unusually late in most U.S. regions during July 2025–June 2026, and cumulative RSV-associated hospitalization rates were lower than those during 2022–2025.
Which age groups had the highest RSV hospitalization rates in 2025–2026?
Infants younger than 12 months had the highest annual rate at 790.2 per 100,000, followed by children aged 12–23 months at 611.9 and adults 75 and older at 352.1, according to the CDC report.
How many children died from RSV and COVID-19 in the 2025–2026 season?
Newly established national surveillance provisionally identified 34 RSV-associated pediatric deaths from 35 reporting jurisdictions and 31 COVID-19–associated pediatric deaths from 43 reporting jurisdictions. CDC says some deaths are likely missed because the counts are provisional.
What SARS-CoV-2 variants circulated in the US in 2025–2026?
Most sequenced SARS-CoV-2 viruses were JN.1-lineage descendants, according to the CDC report. Detections of BA.3.2, described as a highly divergent variant, increased.
Sources
- CDC: Respiratory Virus Activity - United States, July 2025–June 2026 (Weekly, November 19, 2026) — tools.cdc.gov (2026-11-19). tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=766875
This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.


